Investment ThemesDetailed Quotes
Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

  • 1461.083
  • -12.344-0.84%
Close Mar 25 16:00 ET
1475.620High1449.858Low
Constituent Stocks: 10Top Rising: VRTX-0.53%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
VRTXVertex Pharmaceuticals
509.040-2.700-0.53%1.01M512.09M511.780511.740512.710503.985130.72B130.31B256.79M255.99M-0.62%+4.24%+5.97%+24.71%+9.45%+22.36%+26.41%--0.39%LossLoss1.71%Biotechnology
AAgilent Technologies
120.510-1.460-1.20%1.61M194.08M122.600121.970123.040119.76034.36B34.23B285.10M284.06M-2.10%-0.43%-10.19%-11.29%-18.56%-16.63%-10.29%0.79%0.57%27.6427.202.69%Diagnostics & Research
BLUEbluebird bio
3.850-0.070-1.79%244.28K941.11K3.8903.9203.9103.81037.50M37.25M9.74M9.68M-2.28%-2.78%-4.23%-50.58%-62.95%-85.85%-53.84%--2.53%LossLoss2.55%Biotechnology
APLSApellis Pharmaceuticals
23.760-0.500-2.06%1.49M35.33M24.38024.26024.43023.3702.98B2.00B125.52M84.23M-2.66%-6.90%-11.67%-28.69%-17.61%-57.21%-25.54%--1.77%LossLoss4.37%Biotechnology
BEAMBeam Therapeutics
23.220-0.790-3.29%2.39M55.33M23.91024.01024.04522.6402.32B2.00B99.84M85.92M+2.79%-12.10%-22.18%-19.40%-5.22%-31.08%-6.37%--2.79%LossLoss5.85%Biotechnology
SGMOSangamo Therapeutics
0.839-0.031-3.54%3.70M3.15M0.8800.8700.8800.827188.58M183.64M224.71M218.82M-0.82%-15.39%-12.23%-66.43%-3.11%+30.78%-17.73%--1.69%LossLoss6.13%Biotechnology
CRSPCRISPR Therapeutics
40.890-1.730-4.06%1.64M67.73M42.50042.62042.50040.7803.51B3.45B85.77M84.34M-0.20%-3.49%-8.13%-0.12%-12.96%-42.47%+3.89%--1.95%LossLoss4.04%Biotechnology
CRBUCaribou Biosciences
0.960-0.060-5.84%1.91M1.83M1.0401.0201.0400.91989.32M80.62M93.00M83.94M+1.06%-10.24%-22.55%-43.17%-51.00%-81.84%-39.60%--2.27%LossLoss11.83%Biotechnology
NTLAIntellia Therapeutics
8.730-0.580-6.23%3.87M33.83M9.3209.3109.3608.585903.71M854.78M103.52M97.91M-5.01%-6.13%-18.49%-27.55%-57.52%-67.46%-25.13%--3.95%LossLoss8.32%Biotechnology
EDITEditas Medicine
1.300-0.090-6.47%1.38M1.81M1.3801.3901.3901.280107.87M107.41M82.98M82.62M-1.14%-11.56%-30.11%+7.44%-61.88%-82.34%+2.36%--1.67%LossLoss7.91%Biotechnology

News

Comments

Read more